Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar with the matter said, as it seeks to strengthen its foothold in the world's ...

India emerges as key battleground for GLP-1 drugs Novo races to counter Lilly's Mounjaro in India Generics loom as semaglutide patent expiry nears in 2026 HYDERABAD, India, Dec 3 (Reuters) - Danish ...

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention ...

One has to wonder how long the Penn State Nittany Lions can go without putting together a plan at head coach, because their 2026 recruiting class is being absolutely pillaged as their future looks ...

Novo Nordisk has come up short in two phase 3 trials of semaglutide as a treatment for Alzheimer’s disease (AD). But perhaps the larger story associated with the unsurprising result is the market ...

Shares in the Danish pharmaceutical giant Novo Nordisk fell by 10% after the drugmaker announced its oral semaglutide failed to show benefits in slowing the progression of Alzheimer’s disease.

This video features a quarter-mile drag race between the naturally aspirated BMW M3 E92 and the turbocharged Nissan GT-R R33. It highlights the contrast between high-rev V8 power and boosted AWD ...

Disclosure: When you purchase through links on our site, we may earn an affiliate commission. A Wifi smart socket, also known as a smart plug, is an electronic gadget that allows you remotely switch ...